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Abstract
Background: Jaundice is one of the most common problems encountered in newborn infants, due to immaturity of hepatic
conjugation and transport processes for bilirubin. Although the majority of neonatal jaundice is benign, some neonates
with severe hyperbilirubinemia develop bilirubin encephalopathy or kernicterus. Accumulation of unconjugated bilirubin
(UCB) in selected brain regions may result in temporary or permanent impairments of auditory, motor, or cognitive function;
however, the molecular mechanisms by which UCB elicits such neurotoxicity are still poorly understood. The present study
is undertaken to investigate whether prolonged exposure of rat organotypic hippocampal slice cultures to UCB alters the
induction of long-term synaptic plasticity.
Methodology/Principal Findings: Using electrophysiological recording techniques, we find that exposure of hippocampal
slice cultures to clinically relevant concentrations of UCB for 24 or 48 h results in an impairment of CA1 long-term
potentiation (LTP) and long-term depression (LTD) induction in a time- and concentration-dependent manner. Hippocampal
slice cultures stimulated with UCB show no changes in the secretion profiles of the pro-inflammatory cytokines, interleukin-
1b and tumor necrosis factor-a, or the propidium ioide uptake. UCB treatment produced a significant decrease in the levels
of NR1, NR2A and NR2B subunits of N-methyl-D-aspartate (NMDA) receptors through a calpain-mediated proteolytic
cleavage mechanism. Pretreatment of the hippocampal slice cultures with NMDA receptor antagonist or calpain inhibitors
effectively prevented the UCB-induced impairment of LTP and LTD.
Conclusion/Significance: Our results indicate that the proteolytic cleavage of NMDA receptor subunits by calpain may play
a critical role in mediating the UCB-induced impairment of long-term synaptic plasticity in the hippocampus. These
observations provide new insights into the molecular mechanisms underlying UCB-induced impairment of hippocampal
synaptic plasticity which, in turn, might provide opportunities for the development of novel therapeutic strategies that
targets these pathways for treatment.
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Introduction
Bilirubin, an oxidative end product of heme catabolism, is
excreted by liver after glucuronidation by hepatic uridine
diphosphate-glucuronyl transferase [1]. Hyperbilirubinemia is
one of the most common clinical phenomena observed in the
neonatal period. Nearly all newborn infants may experience
temporary, mild to moderate ‘physiological’ jaundice, due to
immaturity of hepatic conjugation and clearance processes for
unconjugated bilirubin (UCB) [2]. In the vast majority of cases,
neonatal jaundice represents a benign phenomenon and the
modest elevation of plasma UCB may exert neuroprotective effects
owing to its antioxidant properties [3]. Some newborns, however,
especially preterm infants with hemolytic diseases, the concentra-
tion of UCB may rise to higher levels that cause bilirubin
encephalopathy or may progress to kernicterus resulting in severe
neurological dysfunctions [2]. The brain regions particularly
vulnerable to UCB toxicity include the cerebellum, cochlear and
oculomotor nuclei of the brain stem, the hippocampus, and the
basal ganglia [4]. The core clinical features of UCB encephalop-
athy may range from mild mental retardation and subtle cognitive
disturbances to deafness and severe cerebral palsy, seizure or death
from kernicterus [2,5]. Data from several prospective controlled
studies have revealed cognitive disturbances in children with
elevated levels of UCB in the infant period [6–9]. Hence,
considerable interest is now focused on understanding the
molecular mechanisms by which UCB exerts such neurodevelop-
mental abnormality in order to generate effective therapeutic
strategies targeting these pathways for treatment. Because
mechanistic studies in humans are limited, a plausible way to
address this question is to use an experimental model that
simulates the clinically relevant UCB concentration exposure in
the developing brain.
Activity-dependent persistent synaptic modifications are gener-
ally thought to be the cellular mechanisms underlying the
refinement of neuronal connections in the developing nervous
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memory in the mature brain [12,13]. Persistent synaptic
modifications can involve alterations in both of the function of
synaptic transmission and the structure of neuronal connections.
Studies of synaptic plasticity have shown that repetitive electrical
activity can rapidly induce persistent changes in the strength of
synaptic transmission, known as long-term potentiation (LTP) and
long-term depression (LTD) [14,15]. The molecular mechanisms
of LTP and LTD have been extensively characterized [16],
especially in hippocampus, has been implicated in memory
formation of spatial learning tasks in rodents an area implicated
in spatial memory formation in rodents [17]. Induction of LTP
and LTD in the CA1 region of the hippocampus involves
numerous protein kinases and/or phosphatases [13,18], which are
believed to be critical for the translation of electrical activity into
persistent subcellular alterations that may modulate synaptic
strength. Interestingly, the adult rats received a bolus intravenous
injection of either 30 mg/kg or 60 mg/kg of bilirubin has been
found to inhibit the induction of LTP in the hippocampal CA3
region in vivo [19]. Thus, we assumed that UCB might affect the
cognitive development during neonatal life through changes in the
bidirectional hippocampal synaptic plasticity.
In the present study, we used rat organotypic hippocampal slice
cultures, which maintain cytoarchitecture of the intact brain and
are well suited for prolonged pharmacological treatments [20,21],
to investigate whether prolonged clinically relevant UCB concen-
tration treatment may alter the induction of CA1 LTP and LTD
and characterize the possible underlying mechanisms. Our data
constitute the first evidence that UCB-induced impairment of CA1
LTP and LTD induction in the hippocampus occurs through the
stimulation of calpain-mediated proteolytic cleavage of N-methyl-
D-aspartate (NMDA) receptor subunits.
Results
Effect of prolonged UCB exposure on basal synaptic
transmission
We initially examined whether the basal synaptic transmission
at the Schaffer collateral-CA1 synapses was altered by prolonged
UCB exposure. The stimulus-response relationships for extracel-
lular field excitatory postsynaptic potentials (fEPSPs) obtained
from UCB exposure and control slices were compared. As shown
in Figure 1A, exposure of UCB at a concentration of 1 mM for
24 h had no effect on the stimulus-response curve, maximal
response, and fEPSP waveform. In contrast, when exposure of
slices to 1 mM UCB for 48 h or the concentration of UCB was
increased to 10 mM for 24 or 48 h, the stimulus-response curve
significantly exhibited a rightward shift (p,0.05) and the maximal
response of fEPSPs was significantly reduced (Figure 1A and B). In
order to test whether the deficit in fEPSPs were due to the
alterations in the excitability of the afferent fibers, we measured
the presynaptic fiber volley amplitude in the presence of AMPA/
kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX, 20 mM) and NMDA receptor antagonist D-2-amino-5-
phosphonovalerate (D-APV, 50 mM) and found no difference in
slices treated 10 mM UCB for 24 or 48 h compared with the
control slices at all stimulus intensities measured (Figure S1). These
results indicate that prolonged treatment with a higher concen-
tration of UCB (10 mM) can produce a decrease in basal synaptic
transmission without altering the excitability of afferent fibers.
Given the similarity of the results with 24 and 48 h control slices,
the two sets of results were averaged throughout the work.
To determine whether prolonged UCB exposure alters the
presynaptic function, we examined the paired-pulse facilitation
(PPF), a transient form of presynaptic plasticity in which the
second of two closely spaced stimuli elicits enhanced transmitter
release [22]. As shown in Figure 1C, pairs of presynaptic fiber
stimulation pulses delivered at interpulse intervals of 20, 40, 60,
80, and 100 ms evoked nearly identical amounts of PPF in slices
from UCB (1 mMo r1 0mM) exposure for 24 h and control. In
contrast, exposure of slices with 10 mM UCB for 48 h, but not
1 mM UCB for 48 h, resulted in a significant increase in the
amounts of PPF. These results suggest that the presynaptic
function at the Schaffer collateral-CA1 synapses is altered by
prolonged UCB exposure only at higher concentrations.
Prolonged UCB exposure impairs the induction of long-
term potentiation and long-term depression
To examine the effects of prolonged UCB exposure on long-
term synaptic plasticity, we analyzed the induction of LTP and
LTD in the CA1 region of the hippocampus. We first examined
LTP induced by two 1-sec trains of 100 Hz stimuli separated by
intertrain interval of 20 sec, a protocol that normally produces a
stable LTP of fEPSPs. In control slices, this protocol consistently
induced a robust LTP of fEPSPs, whereas in slices treated with
1 mM UCB for 48 h or 10 mM UCB for 24 h or 48 h, LTP was
significantly impaired (50 min after HFS: control, 126.565.2% of
baseline, n=21; 1 mM UCB for 48 h, 102.564.5% of baseline,
n=11; 10 mM UCB for 24 h, 105.365.5% of baseline, n=8;
10 mM UCB for 48 h, 98.663.4% of baseline, n=10; p,0.05)
(Figure 2A and B). However, no change in LTP induction was
observed in slices treated with 1 mM UCB for 24 h (123.463.9%
of baseline, n=8; p.0.05) (Figure 2A). A LTD-inducing low-
frequency stimulation (LFS, 1 Hz lasting 15 min) was then
delivered to the Schaffer collateral afferent fibers. As shown in
Figure 2C, following the LFS, there was a robust LTD of fEPSPs
in control slices (50 min after the end of LFS: 76.564.3% of
baseline, n=16). The magnitude of LTD was not significantly
affected by treatment of the slices with 1 mM UCB for 24 h
(81.664.8% of baseline, n=8) or 48 h (84.265.1% of baseline,
n=8) or 10 mM UCB for 24 h (84.564.5% of baseline, n=8). In
contrast, LTD was not induced by LFS in slices treated with
10 mM UCB for 48 h (93.563.2% of baseline, n=7) (Figure 2D).
To confirm that the observed deficits in LTP and LTD are not due
to the residual UCB in the slices, we tested the effect of acute
application of UCB (10 mM) on the induction of LTP and LTD in
age-matched slice cultures at 5 days in vitro (DIV). Compared with
the control slices, bath application of 10 mM UCB had no
significant effect on basal synaptic responses and the induction
of LTP (132.665.3% of baseline, n=5) and LTD (79.863.8% of
baseline, n=5) (Figure S2). These results rule out a possible role of
residual UCB in the slices in governing the deficits of LTP and
LTD occurred after prolonged UCB exposure.
The observations that prolonged UCB exposure impairs LTP
and LTD induction suggested the possibility that it may produce
an alteration of synaptic modification properties. To explore this
possibility, we stimulated the Schaffer collateral afferent fibers with
a range of frequencies (5, 10, and 50 Hz) and examined the
consequent changes in the synaptic strength. Our results
experimentally confirmed the theoretical model of synaptic
plasticity originally postulated by Bienenstock, Cooper, and
Munro (BCM) [23]; HFS leads to LTP, intermediate frequency
stimulation produces only a minor or no change in synaptic
strength, and LFS produces LTD. In control slices, 900 pulses of
1 Hz and 5 Hz stimulation induced a LTD of synaptic strength.
Moreover, two 1-sec trains of 50 Hz or 100 Hz stimuli induced a
significant LTP of synaptic strength. No change in the frequency-
response curve was observed in slices treated with 1 mM UCB for
UCB Alters Synaptic Function
PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e5876Figure 1. Effects of prolonged UCB exposure on basal synaptic transmission and paired-pulse facilitation (PPF). (A, B) Input-output
curves of field excitatory postsynaptic potentials (fEPSPs; V/s) versus stimulus intensity (mA) at the Schaffer collateral-CA1 synapses of hippocampal
slice cultures in the absence (control) or presence of 1 or 10 mM UCB for 24 h (A) or 48 h (B). Inset shows example fEPSPs (average of three responses)
recorded in slices from control and UCB-treated slices. (C, D) Comparison of PPF ratio in slices from control and treated with 1 or 10 mM UCB for 24 h
(C) and 48 h (D). The plot summarizes facilitation of the second fEPSP slope relative to first one as a function of the interpulse intervals of 20 to
200 ms. Inset shows example PPF (average of three responses) obtained with interpulse interval of 40 ms in slice from control and UCB-treated slices.
Error bars indicate SEM.
doi:10.1371/journal.pone.0005876.g001
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LFS and the induction of LTP by 50 Hz or 100 Hz by HFS were
impaired in slices treated with 1 mM UCB for 48 h or 10 mM
UCB for 24 and 48 h, respectively (Figure 2E and F). Together
these results suggest that prolonged UCB exposure can induce a
time- and concentration-dependent impairment of the inducibility
for synaptic modification at the Schaffer collateral-CA1 synapses.
Having established that prolonged UCB exposure impairs the
induction of both LTP and LTD, we next asked whether these
effects are mediated by an alteration of NMDA receptor function,
which is critical determinant for the induction of LTP and LTD in
the hippocampal CA1 region [16,18]. To address this issue, we
compared the ratio of NMDA to AMPA receptor components of
evoked excitatory postsynaptic currents (EPSCs) in CA1 pyramidal
neurons of control and UCB-treated slices. We recorded EPSCs
when the cell was clamped at +50 mV. In this condition, both
NMDA and AMPA receptors are activated by synaptically
released glutamate, and their respective contribution to the EPSCs
was determined by pharmacological application of NMDA
receptor antagonist D-APV (50 mM). Exposure of slices to
10 mM UCB for 24 h (0.7160.04, n=6; p,0.05) or 48 h
(0.4960.08, n=6; p,0.05) underwent a significant reduction in
the NMDA/AMPA ratio when compared with control slices
(0.8760.05, n=7) (Figure 3A).
A reduction in the NMDA/AMPA ratio could reflect a reduction
in the function of NMDA receptors, an increase in the function of
AMPA receptors, or a combination of both. To distinguish between
these possibilities, we first examined the effect of UCB on
pharmacologically isolated AMPA receptor-mediated EPSC (EPS-
CAMPA) recorded at a holding potential of 270 mV in the presence
of GABAA receptor antagonist bicuculline methiodide (20 mM) and
NMDA receptor antagonist D-APV (50 mM). As shown in
Figure 3B, the stimulus-response curve of EPSCAMPA was shifted
to the right for the slices exposure of 10 mM UCB for 48 h
comparedwithcurvegeneratedfromthecontrolslices,confirminga
UCB-related reduction in synaptic strength. In addition, the
NMDA receptor-mediated EPSC (EPSCNMDA) was also isolated
at a holding potential of 260 mV in Mg
2+-free aCSF solution
containing bicuculline methiodide (20 mM) and CNQX (20 mM).
Similarly, the stimulus-response for EPSCNMDA was decreased in
slices treated with 10 mM UCB for 48 h compared with control
slices (Figure 3C). Interestingly, at a concentration of 10 mM
treatment for 48 h, UCB caused a significantly greater reduction of
the amplitude of EPSCNMDA (by <45%) than that of EPSCAMPA
(by <25%). Theoretically, equal depression of the AMPA and
NMDA components would indicate involvement of exclusively
presynaptic mechanisms, whereas differences in depression would
alsoindicate involvement of postsynaptic mechanisms. These results
therefore suggest that prolonged UCB exposure not only causes a
decrease in presynaptic transmitter release but also impairs the
postsynaptic NMDA receptor function.
To further verify the effect of UCB on presynaptic transmitter
release, we recorded AMPA receptor-mediated miniature EPSCs
(mEPSCs). As shown in Figure 3D, in slices treated with 10 mM
UCB for 24 h (0.960.2 Hz, n=5; p,0.05) or 48 h (0.660.3 Hz,
n=6;p,0.05), the mean frequency of mEPSCs was significantly
reduced compared with the control slices (1.560.2 Hz, n=8). No
change in the mean amplitude of mEPSCs was observed in slices
treated with 10 mM UCB for 24 or 48 h. Together, these results
suggest that the decrease in the NMDA/AMPA ratio of EPSCs is
mainly attributed to a greater inhibition of UCB on NMDA
receptor-mediated postsynaptic response.
We also compared inhibitory postsynaptic currents (IPSCs)
recorded in CA1 pyramidal neurons of control and UCB-treated
slices. Monosynaptic IPSCs were evoked while clamping the cell at
270 mV in the presence of CNQX (20 mM) and D-APV (50 mM).
Figure S3 depicts the relationship between stimulus intensities and
IPSC amplitudes. We found that the stimulus-response relation-
ships in slices from control and 10 mM UCB treatment for 48 h
are essentially identical, indicating that there are no obvious
changes in GABA-mediated synaptic transmission after prolonged
UCB exposure.
Prolonged UCB exposure increases proteolytic cleavage
of NMDA receptor subunits by calpain
We next identified the possible mechanisms underlying the
reduction of NMDA receptor-mediated synaptic transmission by
prolonged UCB exposure. A decrease in the NMDA receptor-
mediated synaptic transmission could reflect a decrease in the
number of NMDA receptors. To test this possibility, we compared
the protein expression levels of NMDA receptor subunits in the
CA1 region of control and UCB- treated slices by Western blot
analysis. Using antibodies that selectively label NR1, NR2A, or
NR2B subunits, we found that the protein levels of NR1, NR2A,
and NR2B subunits were significantly decreased by 10 mM UCB
treatment for 24 or 48 h (Figure 4). However, no change in the
levels of NR1, NR2A, and NR2B subunits was observed in slices
treated with 1 mM UCB for 24 h. Level of b-actin was not altered
significantly by UCB.
The decrease in the protein expression levels of NMDA
receptor subunits could be preceded by a decrease in gene
expression. Real-time polymerase chain reaction analysis showed
that the mRNA expression profiles for NR1, NR2A, and NR2B
subunits were not significantly changed by 10 mM UCB treatment
for 48 h (p,0.05) (Figure 5). Thus, UCB-induced decrease in
NMDA receptor subunit protein expression is not due to the
change of gene expression profiles.
It has been shown that UCB can reduce glutamate uptake in
astrocytes and in turn induces neuronal injury or death [24,25].
We therefore asked whether the impairment of LTP and LTD
induction observed in UCB-treated slices is attributed to UCB-
mediated excitotoxicity. With propidium iodide (PI) staining, UCB
(1 or 10 mM) treatment for 24 h or 48 h did not result in higher PI
uptake than in control slices (Figure 6A and B). In contrast,
exposure of slice to kainic acid (60 mM) for 24 or 48 h resulted in a
significant increase in the PI staining. These results indicate that
the UCB treatment regimen used in the present study did not
affect neuronal viability.
Figure 2. Prolonged UCB exposure impairs the induction of long-term potentiation (LTP) and long-term depression (LTD) in the
CA1 region of the hippocampus. (A, B) Summary of experiments showing that the slices from 1 mM UCB exposure for 48 h (B) or 10 mM UCB for
24 h (A) or 48 h (B) displayed a deficit in high frequency stimulation (HFS)-induced (two 1-sec trains of 100 Hz stimuli separated by an intertrain
interval of 20 sec) LTP. (C, D) Summary of experiments showing that the slices obtained from control, 1 or 10 mM UCB exposure for 24 h showed a
reliable LTD after a prolonged low-frequency stimulation (LFS, 900 stimuli delivered at 1 Hz) (C), whereas slices from 1 or 10 mM UCB exposure for
24 h did not (D). (E, F) Summary of experiments showing the frequency-response curves in slices from control, 1, or 10 mM UCB exposure for 24 h (E)
or 48 h (F). The percentage changes in synaptic strength from baseline in all slices were measured at 50 min after stimulation at the indicated
frequencies. Error bars indicate SEM. *p,0.05 as compared with the control group by unpaired Student’s t-test.
doi:10.1371/journal.pone.0005876.g002
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PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e5876Figure 3. Effect of prolonged UCB exposure on NMDA/AMPA ratio of excitatory postsynaptic currents (EPSCs) and AMPA receptor-
mediated miniature EPSCs (mEPSCs). (A) NMDA/AMPA ratio of EPSC (at +50 mV) was determined by subtracting the averaged traces obtained in
50 mM D-APV from those collected in its absence and was found to be significantly lower in slices treated with 10 mM UCB for 24 or 48 h compared
with control slices. The intensity of each stimulation was adjusted to evoke the same peak amplitude of EPSCs (<250 pA) in each slice culture.
Representative traces show EPSCs before (1) and after application of D-APV (50 mM) (2) in control and 10 mM UCB-treated slices. The NMDA receptor-
mediated component (3) was derived by subtracting the AMPA receptor-mediated component (2) from the compound EPSC (1). (B) Representative
traces and input-output curves of AMPA receptor-mediated EPSC (EPSCAMPA;a t270 mV in the presence of 20 mM bicuculline methiodide and 50 mM
D-APV) versus stimulus intensity (mA) at the Schaffer collateral-CA1 synapses of hippocampal slice cultures in the absence (control) or presence of
10 mM UCB for 48 h. (C) Representative traces and input-output curves of NMDA receptor-mediated EPSC (EPSCNMDA;a t260 mV in the presence of
20 mM bicuculline methiodide and 20 mM CNQX) versus stimulus intensity (mA) at the Schaffer collateral-CA1 synapses of hippocampal slice cultures
in the absence (control) or presence of 10 mM UCB for 48 h. (D) Representative voltage-clamp recordings of AMPA receptor-mediated mEPSCs (at
270 mV in the presence of 20 mM bicuculline methiodide, 50 mM D-APV, and 1 mM tetrodotoxin) from control slices (left) or slices treated with 10 mM
UCB for 24 h (middle) or 48 h (right). The bar graphs show mean6SEM of the effects of UCB on the average frequency and amplitude of mEPSCs.
Number of experiments is indicated in the parenthesis.* p,0.05 as compared with the control group by one-way ANOVA (Tukey-Kramer test).
doi:10.1371/journal.pone.0005876.g003
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astrocytes to UCB can trigger release of pro-inflammatory
cytokine release such as tumor necrosis factor (TNF)-a and
interleukin (IL)-1b [26,27]. Because these pro-inflammatory
cytokines have an inhibitory effect on the induction of both LTP
and LTD in the hippocampal CA1 region [28–30], we next
investigated whether such mechanism could provide a possible
explanation for the impairment of LTP and LTD induction
observed in UCB-treated slices. A two-way repeated measure
ANOVA of IL-1b showed no significant interaction among group
and time course (F6,116=1.52, p=0.14) (Figure 7A). Likewise, no
significant increase in the level of TNF-a release was observed in
slices treated with 1 mMo r1 0mM UCG for 24 h compared with
the control slices (group6time interaction: F6,137=0.64, p=0.29)
(Figure 7B). These results exclude the involvement of IL-1b or
TNF-a in the inhibitory effect of UCB on hippocampal CA1 LTP
and LTD.
Since a number of previous studies have proposed a role of
NMDA receptors in UCB-induced brain injury [31–33], we then
examined whether UCB would exert its inhibitory effect on
hippocampal synaptic plasticity through NMDA receptor-mediat-
ed mechanisms. Simultaneous treatment of slices with UCB
(10 mM) and the NMDA receptor antagonist D-APV (50 mM) for
48 h induced no significant changes in the levels of NR1, NR2A,
and NR2B subunits (Figure 8A–D). We also evaluated the
contribution of the L-type voltage-gated Ca
2+ channels in the
UCB-induced down-regulation of NMDA receptor subunit
proteins. However, blockade of L-type voltage-gated Ca
2+
channels by nimodipine (10 mM) did not prevent a decrease in
the expression of NMDA receptor subunits induced by 10 mM
UCB treatment for 48 h. In parallel experiments, we also found
that D-APV almost completely abolished UCB-induced impair-
ment of LTP (APV-control: 132.565.3% of baseline, n=10;
APV-UCB 10 mM for 24 h: 134.565.7% of baseline, n=7; APV-
UCB 10 mM for 48 h: 129.765.2% of baseline, n=7; p.0.05)
and LTD induction (APV-control: 76.564.4% of baseline, n=16;
APV-UCB 10 mM for 24 h: 79.465.3% of baseline, n=9; APV-
UCB 10 mM for 48 h: 74.765.1% of baseline, n=7; p.0.05)
(Figure 8E and F). In contrast, UCB-induced decrease in the
frequency of mEPSCs was not significantly affected by co-
treatment with D-APV (UCB: 0.660.3 Hz, n=6; APV-UCB:
0.860.3 Hz, n=5; p.0.05) (Figure S4). In this series of
experiments, to prevent the residual D-APV in the slices to affect
the induction of LTP and LTD, slices were maintained in the
perfusing chamber for a minimum of 1 h prior to recording, a
period at least over which D-APV was washed out of the slices.
These results indicate a decisive role of NMDA receptors in
mediating the cellular effects of UCB.
On the basis of the data demonstrating the downregulation of
NR1, NR2A and NR2B subunit levels after prolonged UCB
exposure, it was assumed that the decrease in the number of
NMDA receptors may account for the inhibitory effects of UCB
on LTP and LTD induction. One mechanism that could produce
this effect is an increase in the proteolytic cleavage of NMDA
receptor subunits. Because biochemical studies have clearly
demonstrated that the c-terminal region of the NR2 subunit is a
Figure 4. Prolonged UCB exposure decreases the protein levels of NMDA NR1, NR2A and NR2B subunits in rat organotypic slice
cultures. (A) Representative immunoblots showing 10 mM UCB treatment for 48 h decreases NR1, NR2A and NR2B subunit expression in the
hippocampal CA1 homogenate fractions. (B–D) Corresponding densitometric analysis showing the relative levels of NR1 (B), NR2A (C), and NR2B (D)
subunits similar to those shown in (A). Number of experiments is indicated in the parenthesis. Error bars indicate SEM. *p,0.05 as compared with the
control group by unpaired Student’s t-test.
doi:10.1371/journal.pone.0005876.g004
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36], we sought to assess whether calpain-mediated NR2 subunit
cleavage is involved in the mechanism leading to UCB-induced
decrease in NMDA receptor number. To test this premise, we first
used calpain-mediated spectrin and NR2B subunit cleavage as
markers for calpain activation. Western blot analysis found that
UCB (10 mM) treatment significantly induced a time-dependent
increase in spectrin and NR2B subunit cleavage compared with
control slices (Figure 9A). The level of b-actin, a poor calpain
substrate [37], was not affected. To directly quantify total amount
of intracellular calpain activity, a fluorescent peptide Suc-LLVY-
AMC was used as a substrate for calpain [38]. Similarly, we
observed a significant increase in calpain activity within 20 min
after UCB (10 mM) treatment and the levels were stable over time
(Figure 9B). The increased levels of calpain activity correlated
temporally with the spectrin and NR2B subunit cleavage analyzed
by Western blot analysis. Furthermore, in slices treated with
10 mM UCB for 24 h, the calpain activity was significantly
increased (153.6614.5%, n=9; p,0.05), which was completely
blocked by simultaneous addition of D-APV (50 mM, 87.968.2%,
n=4) or the specific calpain inhibitors, leupeptin (100 mM,
112.1610.2%, n=7) and calpeptin (100 mM, 95.367.6%, n=5)
(Figure 9C).
To examine the functional consequences of the blockade of
calpain activity on the UCB effects, slices were co-exposure to
UCB (10 mM) and leupeptin or calpeptin. As shown in
Figure 10A–D, both leupeptin (100 mM) and calpeptin (100 mM)
completely prevented UCB-induced down-regulation of NR2A
and NR2B subunit proteins. However, UCB-induced decrease in
NR1 subunit was not affected by addition of either leupeptin or
calpeptin (Figure 10B). In parallel experiments, we also found that
calpeptin completely abolished UCB-induced impairment of LTP
(calpeptin-control: 142.565.6% of baseline, n=10; calpeptin-
UCB 10 mM for 24 h: 135.266.7% of baseline, n=8; calpeptin-
UCB 10 mM for 48 h: 129.564.5% of baseline, n=8; p.0.05)
and LTD induction (calpeptin-control: 72.662.3% of baseline,
n=10; calpeptin-UCB 10 mM for 24 h: 69.564.5% of baseline,
n=9; calpeptin-UCB 10 mM for 48 h: 75.665.4% of baseline,
n=7; p.0.05) (Figure 10E and F). However, simultaneous
treatment with calpeptin had no significant effect on UCB-
induced decrease in mEPSC frequency (UCB: 0.660.3 Hz, n=6;
calpeptin-UCB: 0.760.2 Hz, n=4; p.0.05) (Figure S4). Togeth-
er, these results suggest that calpain activation mediates UCB-
induced down-regulation NMDA receptor number and the
impairment of LTP and LTD induction in the hippocampal
CA1 region.
Discussion
Although the toxic effects of UCB have been documented in
numerous biological systems, the molecular mechanisms underly-
ing its neurotoxicity have not yet been fully clarified. The present
study demonstrates that prolonged exposure of clinically relevant
concentrations of UCB impairs the induction of hippocampal CA1
LTP and LTD in rat organotypic slice cultures. These UCB-
mediated inhibitory effects are mediated, at least in part, through
overstimulation of NMDA receptors, which results in Ca
2+-
induced calpain activation leading to proteolytic cleavage and
degradation of NMDA receptor subunits. In addition, we showed
that such impairments occur before significant UCB-induced
release of the pro-inflammatory cytokines TNF-a and IL-1b or a
decrease in neuronal viability.
It is well established that the induction of LTP and LTD at the
Schaffer collateral-CA1 synapses of the hippocampus requires the
activation of NMDA receptors [16,18]. Inhibition of NMDA
receptors blocks LTP and LTD induction, although recent studies
using pharmacological NMDA receptor subtype blockade ap-
proach has proposed that LTP induction is specifically dependent
on activation of NR2A-containing receptors and LTD requires
activation of NR2B-containg receptors [39,40]. It is therefore
reasonable to hypothesize that a pathological change in the
function of NMDA receptors might be involved in UCB-mediated
impairment of LTP and LTD. Consistent with this hypothesis, we
provide the first evidence that prolonged UCB exposure leads to
decreased protein levels of NR1, NR2A, and NR2B subunits. Our
results further showed that the NMDA to AMPA ratio of EPSCs is
Figure 5. Effect of prolonged UCB exposure on the expression
of NR1, NR2A and NR2B mRNAs. (A–C) Real time-PCR analysis
showing the relative expression of hippocampal CA1 NR1 (A), NR2A (B)
and NR2B (C) mRNAs in slices from control and 10 mM UCB treatment
for 48 h. Number of experiments is indicated in the parenthesis. Error
bars indicate SEM.
doi:10.1371/journal.pone.0005876.g005
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of AMPA receptor-mediated mEPSCs was observed. Given that
the mRNA profiles for NR1, NR2A, and NR2B subunits were not
significantly altered following prolonged UCB exposure, it seems
likely that UCB-induced decrease in NMDA receptor subunit
expression is not due to the change in gene expression
mechanisms. Nevertheless, our data do not allow us to rule out
the possibility that the abnormal intracellular signaling events
downstream of NMDA receptor activation are also involved in the
establishment of UCB-induced impairment of hippocampal long-
term synaptic plasticity. Further studies are needed, however, to
definitively clarify this issue.
The stimulus-response relationships for the fEPSPs and
EPSCAMPA were shifted to the right for the slices treated with
10 mM UCB for 48 h, suggesting that prolonged UCB exposure
may lead to an inhibition of glutamatergic synaptic transmission.
Although a decrease in the synaptic transmission could result from
a reduction in the function of postsynaptic AMPA receptors, a
reduction in presynaptic glutamate release is a more likely
interpretation, because UCB-treated slices exhibited an increase
Figure 6. Effects of prolonged UCB exposure on propidium iodide (PI) staining in hippocampal slice cultures. (A) Representative
images of PI staining in slices from control or treatment with UCB (1 mMo r1 0mM) or kainic acid (60 mM) for 24 or 48 h. (B) Densitometry
quantification of PI staining similar to those shown in (A). Data are expressed as fold of increase over the respective control group. Number of
experiments is indicated in the parenthesis.
doi:10.1371/journal.pone.0005876.g006
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mediated mEPSCs. In addition, we observed no differences in the
amplitude of mEPSCs between UCB-treated and control slices.
The present findings are in line with previous studies demonstrat-
ing that short-term exposure to UCB in vitro [41] or in vivo [42] can
lead to an impairment of synaptic transmission. Regarding
possible mechanisms by which UCB inhibits glutamate release,
one possibility may involve the inhibition of synapsin I
phosphorylation [43], which plays an important role in neuro-
transmitter release process [44].
What mechanism might contribute to UCB-mediated decrease
in the NMDA receptor subunit proteins? Because the decrease in
levels of NMDA receptor subunits observed in UCB-treated slices
is correlated with an increase in calpain activity and the blockade
of calpain activation almost completely abolished the effects of
UCB, we therefore suggest that calpain activation may be
involved. To our knowledge, this is the first demonstration that
calpain activation participates in the action of UCB to promote
NMDA receptor destruction. These observations are compatible
with previous findings showing that the C-terminal regions of
NR2A and NR2B subunits are substrates for calpain in situ and
calpain-mediated proteolytic cleavage of the C-terminus may
result in NMDA receptor degradation and reduced activity [34–
36]. Interestingly, blockade of NMDA receptors but not L-type
voltage-gated Ca
2+ channels also prevented the UCB-mediated
decrease in the NMDA receptor subunits, indicating that
activation of NMDA receptors is critical for the stimulation of
calpain by UCB. This is in line with previous evidence that
NMDA receptor antagonists are capable to prevent UCB-induced
neurotoxicity, both in vivo [31] and in vitro experiments [32,33]. A
pressing question that follows from these observations is that how
UCB might affect NMDA receptor activation. So far, there is no
evidence that UCB can activate NMDA receptors directly. One
possible mechanism is that UCB may decrease the uptake of
glutamate and thus prolong the presence of glutamate in the
synaptic cleft, which ultimately lead to overstimulation of NMDA
receptors [45]. An alternative, but not mutually exclusive,
mechanism may involve functional interactions between UCB
and NMDA receptors leading to the enhanced NMDA receptor
function. Previous evidence has shown that that UCB exposure in
vivo in newborn piglets can increase the binding affinity of NMDA
receptors for MK-801 [46].
A recent study has emphasized the importance of pro-
inflammatory cytokine TNF-a and IL-1b release in UCB-induced
loss of cell viability [27]. In contrast to this view, however, we
found no significant changes in the levels of TNF-a and IL-1b
after UCB exposure. The reason for this discrepancy is not clear
but could be attributed to the use of different doses of UCB
challenges (50 mM versus 10 mM) or cultured model systems
(astroglial cell cultures versus organotypic hippocampal slice
cultures), resulting in stimulating different cellular processes that
may vary in their mode of action. In accordance, we did not find
significant changes in cell viability after UCB exposure. One
argument might be that the organotypic slice culture model is not
suitable for studying inflammatory reactions. Indeed, there is
excellent evidence showing that this system is an ideal model to
study the functional consequences of changes in inflammatory
responses caused by acute or chronic excitotoxic insults [47,48].
The concentration of UCB in the brain and the duration of
exposure to UCB are important determinants of the development
of UCB neurotoxicity [49–51]. Virtually most published studies of
UCB-mediated neurotoxicity have been carried out at concentra-
tions of UCB that exceeded those seen in jaundiced neonates with
clinical signs of bilirubin encephalopathy, rendering uncertain
relevance for the observations to the clinical manifestations of
neurotoxicity [50]. To exclude this concern, we studied the effects
of UCB on the induction CA1 LTP and LTD in developing rat
organotypic hippocampal slice cultures at theoretically calculated
free fraction concentrations of 3 to 30 nM. It is evident that
jaundiced neonates have total serum bilirubin concentrations of 7
to 17 mg/dL and serum bilirubin concentrations higher than
20 mg/dL may cause kernicterus [49,52]. Using the corrected
affinity constants at pH 7.4, it was estimated that the concentra-
tion of free UCB may exceed 70 nM of its maximum aqueous
solubility when total serum concentration exceeds approximately
5 mg/dL [50]. Therefore, the concentrations of UCB used in the
present study are clinically relevant. It is also known that UCB has
multiple physical states, including monomers, oligomers, metasta-
ble aggregates and sedimentable particles [53]. Given the
Figure 7. Effects of prolonged UCB exposure on IL-1b and TNF-
a release in hippocampal slice cultures. Hippocampal slice cultures
were treated with 1 or 10 mM for the indicated time period. IL-1b (A)
and TNF-a (B) concentrations in medium were determined by ELISA.
Error bars indicate SEM. A two-way repeated measure ANOVA was used
to compare the differences of the levels of IL-1b and TNF-a release
between groups and changes in post UCB treatment measurements
over time. Data are obtained from 5–8 independent experiments
performed in duplicate.
doi:10.1371/journal.pone.0005876.g007
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PLoS ONE | www.plosone.org 10 June 2009 | Volume 4 | Issue 6 | e5876Figure 8. Prevention of UCB-mediated inhibitory effects by blockade of NMDA receptors in hippocampal slice cultures. (A)
Representative immunoblots showing protein levels of NR1, NR2A, and NR2B subunits in slices treated with 10 mM UCB for 48 h in the absence or
presence of NMDA receptor antagonist D-APV (50 mM) or L-type voltage-gated Ca
2+ channel blocker nimodipine (10 mM). (B–D) Corresponding
densitometric analysis showing the relative levels of NR1 (B), NR2A (C), and NR2B (D) subunits similar to those shown in (A). Number of experiments is
indicated in the parenthesis.* p,0.05 as compared with the UCB alone group by unpaired Student’s t-test. #p,0.05 as compared with the control
group by unpaired Student’s t-test. (E) Summary of experiments showing the induction of HFS-induced LTP in slices simultaneously treated with
10 mM UCB with D-APV (50 mM) for 24 or 48 h. (F) Summary of experiments showing the induction of LFS-induced LTD in slices simultaneously
treated with 10 mM UCB with D-APV (50 mM) for 24 or 48 h. The superimposed fEPSPs in the inset illustrates respective recordings from example
experiments taken at the time indicated by number. Error bars indicate SEM.
doi:10.1371/journal.pone.0005876.g008
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PLoS ONE | www.plosone.org 11 June 2009 | Volume 4 | Issue 6 | e5876Figure 9. Calpain activation in response to UCB treatment in hippocampal slice cultures. (A) Representative immunoblots showing UCB
(10 mM)-induced a time-dependent cleavages of a-spectrin and NR2B subunit protein for the indicated time period. (B) Summary of experiments
showingUCB(10 mM)-inducedatime-dependent increaseincalpainactivity.CalpainactivitywasmeasuredbycleavageofthefluorescentsubstrateSuc-
LLVY-AMC (80 mM). (C) Schematic representation of the protocols used for studying the basal calpain activity after 10 mM UCB treatment for 24 h. The
bar graphs show mean6SEM of the effects of 10 mM UCB treatment for 24 h on the basal calpain activity in the absence or presence D-APV (50 mM),
nimodipine (20 mM), leupeptin (100 mM), and calpeptin (100 mM). *p,0.05 as compared with the vehicle control group by unpaired Student’s t-test.
doi:10.1371/journal.pone.0005876.g009
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PLoS ONE | www.plosone.org 12 June 2009 | Volume 4 | Issue 6 | e5876Figure 10. Effects of calpain inhibitors on UCB-induced inhibitory effects in hippocampal slice cultures. (A) Representative
immunoblots showing protein levels of NR1, NR2A, and NR2B subunits in slices treated with 10 mM UCB for 48 h in the absence or presence of
calpain inhibitors, leupeptin (100 mM) or calpeptin (100 mM). (B–D) Corresponding densitometric analysis showing the relative levels of NR1 (B), NR2A
(C), and NR2B (D) subunits similar to those shown in (A). Number of experiments is indicated in the parenthesis.* p,0.05 as compared with the UCB
alone group by unpaired Student’s t-test. (E) Summary of experiments showing the induction of HFS-induced LTP in slices simultaneously treated
with 10 mM UCB with calpeptin (100 mM) for 24 or 48 h. (F) Summary of experiments showing the induction of LFS-induced LTD in slices
simultaneously treated with 10 mM UCB with calpeptin (100 mM) for 24 or 48 h. The superimposed fEPSPs in the inset illustrates respective recordings
from example experiments taken at the time indicated by number. Error bars indicate SEM.
doi:10.1371/journal.pone.0005876.g010
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below its maximum aqueous solubility, it is unlikely that the
inhibitory effects of UCB observed in our experimental conditions
were mediated by precipitation of UCB aggregates. Instead, it
seems that UCB executes its action in monomers or other
oligomeric form [54].
In conclusion, our work supports the notion that prolonged
exposure of clinically relevant UCB concentrations may lead to a
time- and concentration-dependent inhibitor effect on the
induction of hippocampal CA1 long-term synaptic plasticity in
rat organotypic slice cultures and, more importantly identifies
specific molecular mechanisms to support this contention. The
data presented here will help elucidate how UCB affects the
signaling pathways in the hippocampus, possibly shedding light on
how elevated levels of UCB in the infant period cause
hippocampal dysfunction leading to temporary or permanent
impairment of mental function. Because calpain inhibition can
prevent the inhibitory effects of UCB on hippocampal neurons,
this study point to calpain inhibitor as a new potential therapeutic
approach for UCB-induced neurotoxicity in the hippocampus.
Finally, our results indicate that the organotypic hippocampal slice
cultures have potential as model system to study mechanisms of
UCB neurotoxicity that can be useful to develop novel therapeutic
strategies.
Materials and Methods
Organotypic hippocampal slice cultures
All experimental procedures were carried out according to the
guidelines laid down by the Institutional Animal Care and Use
Committee of National Cheng Kung University. Organotypic
cultures of the hippocampus were prepared and maintained
according to the standard interface method described previously
[55,56]. Briefly, hippocampi from 6- to 8-d-old male Sprague-
Dawley rats were dissected and cut into 400 mm slices with a
McIlwain tissue chopper (Mickle Laboratory Engineering, Gom-
shall, Surrey, UK). Only slices from the middle third of the
hippocampus were used for culturing. Individual slices that
displayed an intact dentate gyrus and pyramidal cell layer were
transferred to sterile Millicell-CM (Millipore, Bedford, MA)
membrane inserts (0.4 mm) in six-well culture plates with 1 ml
growth medium. The growth medium composition was 50%
minimal essential medium, 25% Hank’s balanced salt solution,
25% heat-inactivated horse serum, 25 mM HEPES, pH 7.3,
supplemented with glutamax (Invitrogen Molecular Probes,
Carlsbad, CA), glucose (6.5 mg/ml), penicillin (100 units/ml;
Invitrogen Molecular Probes) and streptomycin (100 mg/ml;
Invitrogen Molecular Probes). The cultures were grown in an
incubator with 5% CO2 and 95% atmospheric air at 35uC and the
medium was changed the day after slicing.
UCB treatment
Slices were maintained in vitro for a minimum of 3 days prior to
use, a period at least over which tissues recover from experimental
trauma caused by the isolation procedure [48]. Moreover, the use
of this time in culture also matches up to brain growth rate in full-
term neonate [57]. At the start of experiments, the culture medium
was replaced with 1 ml of serum-free neurobasal medium
(Invitrogen Molecular Probes) with 1 mM L-glutamine, and B27
supplement (Invitrogen Molecular Probes). UCB was obtained
from Sigma (St Louis, MO) and purified according to the method
of McDonagh [58]. UCB (1 or 10 mM), in the presence of human
serum albumin (HSA, 2 or 20 mM), was added to the medium for
24 or 48 h at 35uC. A 10 mM UCB stock solution in 0.1 M
NaOH was prepared immediately before use under light
protection to avoid photodegradation; the pH was restored to
7.4 by addition of equal amounts of 0.1 M HCl. Control slices
were processed in parallel without addition of UCB. Under the
present experimental conditions, the theoretically calculated free
fraction of UCB concentrations were 3 and 30 nM, respectively,
according to the model proposed by Weisiger et al. [59]. These
free UCB concentrations were below the aqueous solubility limit of
70 nM [50]. In order to characterize the cellular mechanisms by
which UCB can affect the induction of LTP and LTD, slice
cultures were additionally treated, in some experiments, with
calpain inhibitors, NMDA receptor antagonist, or L-type voltage-
gated Ca
2+ channel blocker. For this purpose, the calpain
inhibitors, leupeptine (100 mM) and calpeptin (100 mM), NMDA
receptor antagonist, D-APV (50 mM), as well as L-type voltage-
gated Ca
2+ channel blocker, nimodipine (10 mM), were added to
the culture medium, respectively, just before UCB administration
and then left for 24 or 48 h. D-APV, nimodipine, leupeptine, and
calpeptin were purchased from Tocris Cookson (Bristol, UK). All
reagents were added to medium, which was equilibrated at 35uC,
5% CO2 before their addition to the slices. Drug concentrations
were selected on the basis of previously published studies or our
preliminary results.
Electrophysiological recordings
Slice cultures on membrane inserts were transferred to a
submersion-type recording chamber continually perfused with 30–
32uC oxygenated (95% O2–5% CO2) artificial cerebrospinal fluid
(aCSF) solution containing (in mM): 117 NaCl, 4.7 KCl, 2.5
CaCl2, 1.2 MgCl2, 25 NaHCO3, 1.2 NaH2PO4 and 11 glucose.
Extracellular and whole-cell patch-clamp recordings were carried
out with Axoclamp-2B or Axopatch 200B amplifier (Axon
Instruments, Foster City, CA) as described previously [60]. The
responses were low pass filtered at 2 kHz, digitally sampled at 5–
10 kHz, and analyzed using pCLAMP software (Version 8.0;
Axon Instruments). The evoked postsynaptic responses were
induced in CA1 stratum radiatum by stimulation (0.02 ms
duration) of Schaffer collateral/commissural afferents at
0.033 Hz with a bipolar stainless steel stimulating electrode. Field
EPSPs were recorded with a glass pipette filled with 1 M NaCl (2–
3M V resistance) and the initial slope was measured. The strength
of synaptic transmission was quantified by measuring the slope of
fEPSP. PPF was assessed by using a succession of paired pulses
separated by intervals of 20, 40, 60, 80, 100, and 200 ms. LTP was
induced by high-frequency stimulation, at the test pulse intensity,
consisting of two 1-sec trains of stimuli separated by an intertrain
interval of 20 sec at 100 Hz. LTD was induced using a standard
protocol of 900 stimuli at 1 Hz. The stimulation intensity during
low-frequency stimulation application was the same as the test
pulse intensity. Whole-cell recording of EPSCs was made from
CA1 pyramidal cells, which were identified under a DIC
microscope. For EPSC recordings, patch pipettes (3–5 MV) filled
with the following internal solution were used (in mM): 130
CsMeSO3, 8 NaCl, 10 HEPES, 0.5 EGTA, 4 Na2ATP, 0.3
Na3GTP, 5 QX-314 N-(2,6-Dimethyl-phenylcarbamoylmethyl)
triethylammonium bromide; which had an osmolarity of 290–
295 mOsm and pH of 7.2. The amplitude of evoked EPSCs was
measured. To ensure stability of the whole-cell recordings,
electrical stimulation was initiated before the cell was patched.
We waited for approximately 5 min in the cell-attached
configuration before break-in to wash off any residual internal
solution spilled from the approaching pipette. For recording the
ratio of NMDA to AMPA receptor component of EPSCs, cells
were clamped at +50 mV to reduce Mg
2+ blockade of the NMDA
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the same peak amplitude of EPSCs (<250 pA) in each slice
culture. The NMDA/AMPA ratio was determined by subtracting
the averaged traces obtained in D-APV (50 mM) from those
collected in its absence. EPSCAMPA was recorded in the presence
of D-APV (50 mM) and bicuculline methiodide (20 mM) at a
holding potential of 270 mV. When recording EPSCNMDA, cells
were clamped at 260 mV in Mg
2+-free aCSF containing CNQX
(20 mM) and bicuculline methiodide (20 mM). For recording
IPSCs, cells were clamped at 270 mV in the presence of CNQX
(20 mM) and D-APV (50 mM). The composition of intracellular
solution for recording IPSCs was (mM): 150 CsCl, 10 HEPES, 2
MgCl2, 0.5 EGTA, 4 Na2ATP, 0.3 Na3GTP, 5 QX-314. In the
experiments involving recordings of AMPA receptor-mediated
mEPSCs, slices were bathed in the presence of bicuculline
methiodide (20 mM), D-APV (50 mM), and tetrodotoxin (1 mM).
Neurons were held at 270 mV and spontaneous activity was
recorded. The software detects events based on amplitudes
exceeding a threshold set just above the baseline noise of the
recording (23 pA). All detected events were re-examined and
accepted or rejected based on subjective visual examination.
Background current noise was estimated from the baseline with no
clear event and was subtracted from signals for analysis. The
mEPSC frequencies were calculated by dividing the total number
of detected events by the total time sampled. Series and input
resistances were monitored throughout each experiment. Data
were discarded if series resistance changed more than 15% during
an experiment.
Western Blotting
The microdissected slice samples for each experimental
condition were transferred into ice-cold lysis buffer (pH 7.4)
containing a cocktail of protein phosphatase and proteinase
inhibitors (50 mM Tris-HCl, 100 mM NaCl, 15 mM sodium
pyrophosphate, 50 mM sodium fluoride, 1 mM sodium orthova-
nadate, 5 mM EGTA, 5 mM EDTA, 1 mM phenylmethylsulfonyl
fluoride, 1 mM microcystin-LR, 1 mM okadaic acid, 0.5% Triton
X-100, 2 mM benzamidine, 60 mg/ml aprotinin, and 60 mg/ml
leupeptin) to avoid dephosphorylation and degradation of
proteins, and ground with a pellet pestle (Kontes glassware,
Vineland, NJ). Samples were sonicated and spun down at
15,0006ga t4 uC for 10 min. The supernatant was then assayed
for total protein concentration using Bio-Rad Bradford Protein
Assay Kit (Hercules, CA). Each sample was separated in 7% SDS-
PAGE gel. Following the transfer on nitrocellulose membranes,
blots were blocked in TBS containing 3% bovine serum albumin
and 0.01% Tween 20 for 1 h and then blotted for 2 h at room
temperature with antibody that recognize NR1 (1:1000; Chemi-
con, Temecula, CA), NR2A (1:1000; Santa Cruz Biotechnology,
Santa Cruz, CA), NR2B (1:1000; Santa Cruz Biotechnology),
NR2B (an N-terminal antibody to 251 amino acid sequence,
1:500; Zymed Laboratories Inc., San Francisco, CA), spectrin
(1:500; Biomol, Plymouth Meeting, PA) or b-actin (1:20000;
Sigma-Aldrich, St Louis, MO). It was then probed with HRP-
conjugated secondary antibody for 1 h and developed using the
ECL immunoblotting detection system (Amersham Pharmacia
Biotech, Piscatway, NJ). Immunoblots were analyzed by densi-
tometry using Bio-profil BioLight PC software. Only film
exposures that were in the linear range of the ECL reaction were
used for quantification analysis. Expression of NR1, NR2A and
NR2B was evaluated relative to that for b-actin. Background
correction values were subtracted from each lane to minimize the
variability across membranes.
Quantitative Real-Time RT-PCR
Total RNA was isolated from frozen hippocampal CA1 region
of the slice cultures using TriReagent kit (Molecular Research
Center, Cincinnati, OH), treated with RNase-free DNase (RQ1;
Promega, Madison, WI) to remove the potential contamination of
genomic DNA. Approximately 1 ng of RNA was reverse-
transcribed and amplified following the quantitative one-step
real-time RT-PCR technique (Titanium One-Step RT-PCR kit,
BD Biosciences Clontech, Palo Alto, CA), with both RT and PCR
in the same tube. Real-time RT-PCR was performed on the
Roche LightCycler instrument (Roche Diagnostics, Indianapolis,
IN) using the FastStart DNA Master SYBR Green I kit (Roche
Applied Science) as described by the manufacturer. The PCR
mixtures were incubated at 95uC for 10 min, and then 35 PCR
cycles were conducted (95uC for 10 sec, 55uC for 15 sec and 68uC
for 20 sec). The primer combinations were designed by referring
to the rat studies by Pickering et al. [61] and Ku et al. [62]: NR1
59-CTGCAACCCTCACTTTTGAG-39 (forward) and 59-
TGCAAA AGCCAGCTGCATCT-59 (reverse); NR2A, 59-
GACGGTCTTGGGATCTTA AC-39 (forward) and 59-TGAC-
CATGAAATTGGTGCAGG-39 (reverse); NR2B 59-TGC
ACAATTACTCCTCGACG-39 (forward) and 59-
TCCGATTCTTCTTCTGAGCC-39 (reverse); b-actin, 59-
TTCTACAATGAGCTGCGTGTGGC-39 (forward) and 59-
CTCATAGCTCTTCTCCAGGGAGGA-39 (reverse). Real-time
RT-PCR reactions on mRNA obtained from control or neonatal
isolated rat hippocampal CA1 total RNA samples were performed
at the same time. PCR amplifications were repeated in duplicate.
A melting curve was created at the end of the PCR cycle to
confirm that a single product was amplified. Data were analyzed
by the LightCycler quantification software to determine the
threshold cycle above the background for each reaction. The
relative transcript amount of the gene of interest, which was
calculated using standard curves of serial RNA dilutions, was
normalized to that of b-actin of the same RNA.
Assessment of neuronal damage by propidium iodide
uptake
Neuronal death inthe slice cultures was assessed by measurement
of the fluorescent exclusion dye propidium iodide (PI; Invitrogen
Molecular Probes) uptake as described in detail elsewhere [47]. PI
only enters cells with damaged cell membrane, interacting with
DNA to yield a bright red fluorescence. PI (5 mg/ml) was added to
the culture medium together with different treatment. After 3 h
incubation, PI fluorescence was visualized using a 56objective with
a fluorescent microscope (Olympus BX51, Tokyo, Japan), and
images of PI-labeled slices were captured with a digital camera
system (Olympus Optical DP70). Except for adjustment to the
contrast and brightness levels, no other manipulations were done in
any of the images. Images were analyzed quantitatively by
densitometry with NIH Image 1.62 analysis software.
Quantification of IL-1b and TNF-a release by ELISA
The culture supernatants from control and treated slice cultures at
appropriate time points was collected, centrifuged at 6006gf o r5m i n ,
and stored in aliquots at 270uC. Concentrations of IL-1b and TNF-a
were measured with commercial DuoSet ELISA Development kit (R
& D Systems, Minneapolis, MN) according to the manufacturer’s
instructions. IL-1b and TNF-a levels are expressed as pg/ml.
Calpain activity assay with Suc-LLVY-AMC
Cleavage of the fluorogenic calpain substrate Succinyl-Leu-Leu-
Val-Tyr-7-amino-4-methylcoumarin (Suc-LLVY-AMC; Calbio-
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measure intracellular calpain activity as described previously [36].
Suc-LLVY-AMC (80 mM) was added to the culture medium
together with different treatment. After 1 h incubation, the slice
culture samples for each experimental condition were transferred
into ice-cold lysis buffer, sonicated, and spun down at 15,0006ga t
4uC for 15 min. The supernatant was then assayed for total
protein concentration using Bio-Rad Bradford Protein Assay Kit
(Hercules, CA) and for calpain activity assay. The fluorescence was
assessed using a 96-well fluorescent microplate reader (Gemini
Spectra XPS, Molecular Devices, Union City, CA) with a 365 nm
excitation and a 460 nm emission. In some experiments, slice
cultures were pretreated Suc-LLVY-AMC (80 mM) for 30 min
before UCB added and calpain activity was assayed from 0 to
60 min after UCB application.
Data Analysis
All data are expressed as means6SEM, and unless stated
otherwise, the statistic significance was determined using a one-
way analysis of variance (ANOVA) for repeated measurements
with a post-hoc Tukey-Kramer test or Student’s t-test. We used a
two-way repeated measure ANOVA to compare the differences of
the levels of IL-1b and TNF-a release between groups and
changes in post UCB treatment measurements over time. The
Fisher’s protected LSD post-hoc test was used for pair-wise
comparisons after ANOVA. Probability values of p,0.05 were
considered to represent significant differences. All data analyses
were performed using SPSS commercially available statistical
analysis software (SigmaStat Version 2.0; Chicago, IL, USA).
Supporting Information
Figure S1 Effects of prolonged UCB exposure on the presyn-
aptic fiber volley. Input-output curves of the amplitude of
presynaptic fiber volley versus stimulus intensity (mA) at the
Schaffer collateral-CA1 synapses of hippocampal slice cultures in
the absence (control, n=5) or presence of 10 mM UCB for 24
(n=5) or 48 h (n=5). Representative traces (average of three
responses) show example fiber volley recorded in slices from
control and UCB-treated slices in the presence of CNQX (20 mM)
and D-APV (50 mM).
Found at: doi:10.1371/journal.pone.0005876.s001 (7.01 MB TIF)
Figure S2 Effects of acute UCB exposure on the induction of
LTP and LTD in the CA1 region of the hippocampus. (A)
Summary of experiments showing that bath application of UCB
(10 mM, n=5) had no significant effect on basal synaptic
transmission and the induction of HFS-induced LTP in slice
cultures at 5 DIV. (B) Summary of experiments showing that bath
application of UCB (10 mM, n=5) had no significant effect on the
induction of LTD by LFS in slice cultures at 5 DIV.
Representative traces of fEPSPs were taken at the time indicated
by number. Error bars indicate SEM.
Found at: doi:10.1371/journal.pone.0005876.s002 (5.33 MB TIF)
Figure S3 Effects of prolonged UCB exposure on the inhibitory
postsynaptic currents (IPSCs). Input-output curves of the ampli-
tude of IPSCs versus stimulus intensity (mA) at the Schaffer
collateral-CA1 synapses of hippocampal slice cultures in the
absence (control, n=5) or presence of 10 mM UCB for 48 h
(n=5). Representative traces show example IPSCs (average of
three responses) recorded in slices from control and UCB-treated
slices at 270 mV in the presence of CNQX (20 mM) and D-APV
(50 mM).
Found at: doi:10.1371/journal.pone.0005876.s003 (4.18 MB TIF)
Figure S4 Effects of D-APV and calpeptin on UCB-induced
decrease in the frequency of mEPSCs. The bar graphs show
mean6SEM of the effects of UCB (10 mM) on the average
frequency (A) and the amplitude (B) of AMPA receptor-mediated
mEPSCs in slices simultaneously treated with D-APV (50 mM) or
calpeptin (100 mM) for 48 h. Number of experiments is indicated
in the parenthesis. *p,0.05 as compared with the control group
by one-way ANOVA (Tukey-Kramer test).
Found at: doi:10.1371/journal.pone.0005876.s004 (4.09 MB TIF)
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